What to Expect:
This program provides a summary of recent literature related to CHEK2-associated cancer risks and management implications. Our speakers will evaluate current evidence that compares the cancer risks associated with different types of germline CHEK2 variants.

Learning Objectives:

  • Identify challenges of CHEK2 variant classification as reviewed in recent clinical practice guidelines.
  • Define evidence for cancer risk associated with germline pathogenic variants (PV) in CHEK2
  • Examine management implications for CHEK2-associated cancer risks.
  • Summarize recent evidence comparing cancer risks between individuals with different types of germline CHEK2 variants.


Irene Rainville, MS, PhD, LCGC
Erin Mundt, MS, CGC

This nursing continuing professional development activity is approved for 1.25 contact hours from Oregon Nurses Association (ONA), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). Contact hours will be awarded to participants who view the entire program recording and complete the post-activity survey.

Click here after viewing the webinar to complete the survey:
Take survey

Please pay close attention to the instructions for receiving your certificate at the end of this survey.  Once you have completed this survey in entirety you will have an option to print or save the image of the certificate. We recommend that you complete this from a desktop or your laptop computer for the best quality and options for saving this file.

Please read the instructions below carefully to obtain your certificate.

IMPORTANT: You must save the image at this time to obtain this certificate for your records.

***You must complete the webinar and survey no later than TBD to claim credit***

Myriad Genetics Lab, a diagnostic lab that does not sell proprietary products, is an eligible organization according to the American Nurses Credentialing Center criteria. There are no relevant financial relationships with any individuals in the position to control content for this educational activity.

Questions or comments?

Webinar Questions